Internal Medicine

The investigators found the primary efficacy endpoints occurred in 20 evaluable patients (87%).

No approved treatment for leber hereditary optic neuropathy is currently available in the United States.

In a joint interview, 2 pediatric cardiologists discuss topics related to remote technologies and cardiological monitoring among pediatric populations.

A Stanford Cardiovascular Institute expert details a recent review into managing a growing field of agents.

Obese individuals were found to have a higher odds ratio of developing IIH compared to non-obese people.

Two pediatric cardiologists stress that recognizing symptoms of MIS-C is essential for primary care providers.

The company plans to submit the data to the FDA and EMA for consideration of the injectable bispecific antibody's regulatory approval for the treatment of both conditions.

A recent study reports that obese patients experienced high immunogenicity compared with those of normal weight.

The indication is the first granted to an ANGPTL3 inhibitor in the US.

The co-lead investigators discuss the upcoming first study to assess long-term outcomes on MIS-C patients.

This approval was granted to generic pharmaceutical company Akorn Operating Company, LLC.

Linaclotide has been marketed as LINZESS to treat irritable bowel syndrome with constipation.

Infants managed using real-time CGM spent longer time in the glucose concentration target range than those receiving standard of care.

Two pediatric cardiologists offer perspective on how to approach conversations about MIS-C with parents or guardians.

The approval is indicated for children ≥5 years old who inadequately respond to or are intolerant of anticholinergic medication.

A meta-analysis review suggests intradermal flu vaccines at lower doses could provide as much immunogenicity as standard intramuscular doses.

FLT201 is a combination of AAVS3 capsid and a liver-specific promotor to drive the expression of GCasevar85.

New data shows that a restrictive blood transfusion strategy resulted in a noninferior rate of major adverse cardiovascular events compared with a more liberal strategy.

Crohn’s disease patients and ulcerative colitis patients showed changes in energetic metabolism in plasma and biopsy samples compared to a control group.

A cohort assessment shows a 57% increased risk of pediatric asthma development among children given PPIs to treat gastrointestinal tract disorders.

Recent clinical trials have shown positive topline results for SPN-812.

The excessive prescribing of opioids post-surgery increases risk of patient morbidity.

A conversation around how burnout, COVID-19, politicization, and career progression programs influence the state of the largest US healthcare team.

Two studies demonstrated that the IL-17A and IL-17F inhibitor can lead to superior levels of skin of clearance in adult patients compared with ustekinumab or placebo. .

The 1 patient who did not received immunomodulatory agents demonstrated the highest level of FVIII activity.